Novel Targets for Breast Cancer
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cancer Biology and Oncology".
Deadline for manuscript submissions: 31 January 2025 | Viewed by 52
Special Issue Editor
Interests: Breast cancer
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Breast cancer persists as one of the most prevalent malignancies among women globally, leading to substantial morbidity and mortality. Despite progress in early detection and treatment, the heterogeneity of breast cancer presents significant challenges in effective disease management. Uncovering and understanding novel therapeutic targets, including those involving immunologic pathways, is essential in developing more effective treatments and enhancing patient outcomes. This Special Issue is dedicated to exploring and identifying new molecular and immunologic targets for breast cancer therapy.
Our objective is to compile pioneering research and reviews that illuminate the molecular and immune mechanisms driving breast cancer, highlighting potential therapeutic targets. By investigating the diverse biological and immunologic pathways involved in breast cancer progression, such as hormone receptor signaling, HER2/neu overexpression, BRCA1/2 mutations, the tumor microenvironment, and immune evasion strategies, this Special Issue will foster innovative treatment approaches.
We anticipate that this Special Issue will make significant contributions to breast cancer research, opening up new avenues for therapeutic strategies and, ultimately, improving prognosis and quality of life for patients living with this disease.
Dr. Kyoung Sik Park
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- breast cancer
- molecular targets
- hormone receptor signaling
- HER2/neu
- BRCA1/2
- tumor microenvironment
- microbiome
- targeted therapy
- precision medicine
- drug resistance
- immunotherapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
